Literature DB >> 11322883

Identification and localization of three photobinding sites of iodoarylazidoprazosin in hamster P-glycoprotein.

B Isenberg1, H Thole, B Tümmler, A Demmer.   

Abstract

P-glycoprotein is an ATP-dependent drug-efflux pump which can transport a diverse range of structurally and functionally unrelated substrates across the plasma membrane. Overexpression of this protein may result in multidrug resistance and is a major cause of the failure of cancer chemotherapy. The most commonly used photoreactive substrate is iodoarylazidoprazosin. Its binding domains within the P-glycoprotein have so far been inferred from indirect methods such as epitope mapping. In this study, the binding sites were refined and relocalized by direct analysis of photolabeled peptides. P-glycoprotein-containing plasma membrane vesicles of Chinese hamster ovary B30 cells were photoaffinity-labeled with iodoarylazidoprazosin. After chemical cleavage behind tryptophan residues or enzymatic cleavage behind lysine residues, the resulting 125I-labeled peptides were separated by tricine/PAGE and HPLC and subjected to Edman sequencing. The major photoaffinity binding sites of iodoarylazidoprazosin were localized in the amino-acid regions 248-312 [transmembrane segment (TM)4 to TM5], 758-800 (beyond TM7 to beyond TM8) and 1160-1218 (after the Walker A motif of the second nucleotide-binding domain). Therefore the binding pocket of iodoarylazidoprazosin is made up of at least three binding epitopes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322883     DOI: 10.1046/j.1432-1327.2001.02155.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Evidence for modulatory sites at the lipid-protein interface of the human multidrug transporter P-glycoprotein.

Authors:  Debjani Mandal; Karobi Moitra; Debabrata Ghosh; Di Xia; Saibal Dey
Journal:  Biochemistry       Date:  2012-03-22       Impact factor: 3.162

2.  Detailed characterization of cysteine-less P-glycoprotein reveals subtle pharmacological differences in function from wild-type protein.

Authors:  A M Taylor; J Storm; L Soceneantu; K J Linton; M Gabriel; C Martin; J Woodhouse; E Blott; C F Higgins; R Callaghan
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.

Authors:  Ioana Abraham; Sandeep Jain; Chung-Pu Wu; Mohammad A Khanfar; Yehong Kuang; Chun-Ling Dai; Zhi Shi; Xiang Chen; Liwu Fu; Suresh V Ambudkar; Khalid El Sayed; Zhe-Sheng Chen
Journal:  Biochem Pharmacol       Date:  2010-08-07       Impact factor: 5.858

4.  Theoretical insights on helix repacking as the origin of P-glycoprotein promiscuity.

Authors:  Cátia A Bonito; Ricardo J Ferreira; Maria-José U Ferreira; Jean-Pierre Gillet; M Natália D S Cordeiro; Daniel J V A Dos Santos
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

5.  Interspecies comparison of putative ligand binding sites of human, rat and mouse P-glycoprotein.

Authors:  Sankalp Jain; Melanie Grandits; Gerhard F Ecker
Journal:  Eur J Pharm Sci       Date:  2018-06-22       Impact factor: 5.112

6.  Lysine 268 adjacent to transmembrane helix 5 of hamster P-glycoprotein is the major photobinding site of iodomycin in CHO B30 cells.

Authors:  Annette Demmer; Hubert Thole; Manfred Raida; Burkhard Tümmler
Journal:  FEBS Open Bio       Date:  2021-02-28       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.